Awareness and knowledge of congenital cytomegalovirus infection among pregnant women and the general public: a web-based survey in Japan.

Journal Information

Full Title: Environ Health Prev Med

Abbreviation: Environ Health Prev Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Environmental Health

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study protocol was approved by the ethics review board of the Medical Corporation Toukeikai Kitamachi Clinic, and all participants provided electronic informed consent. Consent for publicationNot applicable. Competing interestsMK, KO, and NH are employees of MSD K.K., Tokyo, Japan, a subsidiary of Merck & Co., Inc., Kenilworth, N.J., USA., and may own stock and/or hold stock options in Merck & Co., Inc., Kenilworth, N.J., USA. AO has received personal fees from AbbVie, LLC outside of the submitted work. IM has received grants from Japan Blood Product Organization, Eli Lilly Japan K.K., AbbVie LLC, Teijin Pharma Co., Ltd., Chugai Pharmaceutical Co., Ltd., Shionogi Co., Ltd., and JCR Pharmaceuticals Co., Ltd.; lecture fees from MSD Co., Ltd., Pfizer Japan, Inc., Novo Nordisk Pharma Ltd., Shionogi Co., Ltd., AbbVie LLC, Shino-test Corp., and Atom Medical Corp outside of the submitted work. Competing interests MK, KO, and NH are employees of MSD K.K., Tokyo, Japan, a subsidiary of Merck & Co., Inc., Kenilworth, N.J., USA., and may own stock and/or hold stock options in Merck & Co., Inc., Kenilworth, N.J., USA. AO has received personal fees from AbbVie, LLC outside of the submitted work. IM has received grants from Japan Blood Product Organization, Eli Lilly Japan K.K., AbbVie LLC, Teijin Pharma Co., Ltd., Chugai Pharmaceutical Co., Ltd., Shionogi Co., Ltd., and JCR Pharmaceuticals Co., Ltd.; lecture fees from MSD Co., Ltd., Pfizer Japan, Inc., Novo Nordisk Pharma Ltd., Shionogi Co., Ltd., AbbVie LLC, Shino-test Corp., and Atom Medical Corp outside of the submitted work."

Evidence found in paper:

"Funding This paper is sponsored by MSD K.K., Tokyo, Japan. The sponsor was involved in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript."

Evidence found in paper:

"Trial registration UMIN Clinical Trials Registry, UMIN000041260."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025